Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Human-Spongiosa is a freeze-dried human cancellous bone allograft used as a bone substitute material in regenerative dentistry and orthopedics. In the context of clinical research at University Medicine Greifswald, it is utilized for alveolar ridge preservation (socket preservation) following tooth extraction to prevent alveolar bone loss and bone resorption. The material acts as an osteoconductive scaffold, providing a natural trabecular structure that facilitates the migration of osteogenic cells and the formation of new host bone. By maintaining the volume and structural integrity of the alveolar ridge, Human-Spongiosa supports successful delayed dental implantation and helps preserve the aesthetic appearance of the surrounding soft tissue.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Human-Spongiosa.